# UNH — slm-full-cpu

## Metadata

ticker: UNH
arm: slm-full-cpu
judge_prompt_version: v2
context_sha256: 67def17da9f8a0ada0ddb19937d80dd42e5a31ab2c70d15ab339efa59262fd75
slm_endpoint: slm-cpu
slm_url: http://llamacpp.financial-agent.svc:8080
slm_served_name: qwen3.6-35b-a3b-q4km
slm_artifact: ggml-org/Qwen3.6-35B-A3B-GGUF@baec3ebee244827cda0f4557eafa8b28f7545fa6:Qwen3.6-35B-A3B-Q4_K_M.gguf sha256:671e47e0ec53c665d048b98c3ecbfd5236b5ca9c3e02ed19fc8f81f7b85140c7
slm_build: b11347-5fc4f3c8c
slm_model_path: /models/Qwen3.6-35B-A3B-Q4_K_M.gguf
slm_model_ftype: Q4_K - Medium
slm_total_slots: 4
slm_n_ctx: 32768
slm_n_params: 34660610688
slm_model_size_bytes: 20408576512
slm_thinking: off
slm_sampling: {"planner": {"chat_template_kwargs": {"enable_thinking": false}, "dry_multiplier": 0.0, "frequency_penalty": 0.0, "max_tokens": 1024, "min_p": 0.0, "presence_penalty": 0.0, "repeat_penalty": 1.0, "temperature": 0.0, "top_k": 20, "top_n_sigma": -1.0, "top_p": 0.8, "typical_p": 1.0, "xtc_probability": 0.0}, "rag": {"chat_template_kwargs": {"enable_thinking": false}, "dry_multiplier": 0.0, "frequency_penalty": 0.0, "max_tokens": 2048, "min_p": 0.0, "presence_penalty": 0.0, "repeat_penalty": 1.0, "temperature": 0.1, "top_k": 20, "top_n_sigma": -1.0, "top_p": 0.8, "typical_p": 1.0, "xtc_probability": 0.0}, "react": {"chat_template_kwargs": {"enable_thinking": false}, "dry_multiplier": 0.0, "frequency_penalty": 0.0, "max_tokens": 1024, "min_p": 0.0, "presence_penalty": 0.0, "repeat_penalty": 1.0, "temperature": 0.0, "top_k": 20, "top_n_sigma": -1.0, "top_p": 0.8, "typical_p": 1.0, "xtc_probability": 0.0}, "section": {"chat_template_kwargs": {"enable_thinking": false}, "dry_multiplier": 0.0, "frequency_penalty": 0.0, "max_tokens": 768, "min_p": 0.0, "presence_penalty": 0.0, "repeat_penalty": 1.0, "temperature": 0.1, "top_k": 20, "top_n_sigma": -1.0, "top_p": 0.8, "typical_p": 1.0, "xtc_probability": 0.0}, "synthesis": {"chat_template_kwargs": {"enable_thinking": false}, "dry_multiplier": 0.0, "frequency_penalty": 0.0, "max_tokens": 4096, "min_p": 0.0, "presence_penalty": 0.0, "repeat_penalty": 1.0, "temperature": 0.2, "top_k": 20, "top_n_sigma": -1.0, "top_p": 0.8, "typical_p": 1.0, "xtc_probability": 0.0}}
llm_calls: 7
llm_endpoints: slm-cpu
llm_by_site: {"rag:highlights": {"calls": 1, "completion_tokens": 664, "completion_tokens_unrecorded": 0, "errors": 0, "format_failure": 0, "latency_s_max": 185.255, "latency_s_total": 185.255, "parse_failure": 0, "prompt_tokens": 3060, "prompt_tokens_unrecorded": 0, "repeat_run": 0, "retry": 0, "truncated": 0}, "rag:risks": {"calls": 1, "completion_tokens": 375, "completion_tokens_unrecorded": 0, "errors": 0, "format_failure": 0, "latency_s_max": 153.625, "latency_s_total": 153.625, "parse_failure": 0, "prompt_tokens": 3049, "prompt_tokens_unrecorded": 0, "repeat_run": 0, "retry": 0, "truncated": 0}, "section:financial_health": {"calls": 1, "completion_tokens": 179, "completion_tokens_unrecorded": 0, "errors": 0, "format_failure": 0, "latency_s_max": 50.951, "latency_s_total": 50.951, "parse_failure": 0, "prompt_tokens": 835, "prompt_tokens_unrecorded": 0, "repeat_run": 0, "retry": 0, "truncated": 0}, "section:recent_developments": {"calls": 1, "completion_tokens": 144, "completion_tokens_unrecorded": 0, "errors": 0, "format_failure": 0, "latency_s_max": 46.545, "latency_s_total": 46.545, "parse_failure": 0, "prompt_tokens": 829, "prompt_tokens_unrecorded": 0, "repeat_run": 0, "retry": 0, "truncated": 0}, "section:risk_factors": {"calls": 1, "completion_tokens": 140, "completion_tokens_unrecorded": 0, "errors": 0, "format_failure": 0, "latency_s_max": 38.938, "latency_s_total": 38.938, "parse_failure": 0, "prompt_tokens": 446, "prompt_tokens_unrecorded": 0, "repeat_run": 0, "retry": 0, "truncated": 0}, "section:sec_filing_highlights": {"calls": 1, "completion_tokens": 132, "completion_tokens_unrecorded": 0, "errors": 0, "format_failure": 0, "latency_s_max": 73.252, "latency_s_total": 73.252, "parse_failure": 0, "prompt_tokens": 743, "prompt_tokens_unrecorded": 0, "repeat_run": 0, "retry": 0, "truncated": 0}, "synthesis": {"calls": 1, "completion_tokens": 881, "completion_tokens_unrecorded": 0, "errors": 0, "format_failure": 0, "latency_s_max": 138.53, "latency_s_total": 138.53, "parse_failure": 0, "prompt_tokens": 1566, "prompt_tokens_unrecorded": 0, "repeat_run": 0, "retry": 0, "truncated": 0}}

## Retrieved source context

STOCK DATA:
{
  "ticker": "UNH",
  "company_name": "UnitedHealth Group Incorporated",
  "current_price": 371.9,
  "currency": "USD",
  "market_cap": 333815513088.0,
  "pe_ratio": 23.916397,
  "forward_pe": 16.448336,
  "week_52_high": 461.62,
  "week_52_low": 255.97,
  "revenue": 450525986816.0,
  "net_income": 14122000384.0,
  "profit_margin": 0.03135,
  "dividend_yield": 2.5,
  "sector": "Healthcare",
  "industry": "Healthcare Plans"
}

NEWS ARTICLES:
[]

SEC FILING SUMMARIES:
{
  "10-K": {
    "form_type": "10-K",
    "filing_date": "2026-03-02",
    "summary": "ITEM 1A. RISK FACTORS CAUTIONARY STATEMENTS The statements, estimates, projections or outlook contained in this Annual Report on Form 10-K include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (PSLRA). When used in this Annual Report on Form 10-K and in future filings by us with the SEC, in our news releases, presentations to securities analysts or investors, and in oral statements made by or with the approval of one of our executive officers, the words \u201cbelieve,\u201d \u201cexpect,\u201d \u201cintend,\u201d \u201cestimate,\u201d \u201canticipate,\u201d \u201cforecast,\u201d \u201coutlook,\u201d \u201cplan,\u201d \u201cproject,\u201d \u201cshould\u201d or similar words or phrases are intended to identify such forward-looking statements. These statements are intended to take advantage of the \u201csafe harbor\u201d provisions of the PSLRA"
  },
  "10-Q": {
    "form_type": "10-Q",
    "filing_date": "2026-08-10",
    "summary": "ITEM 1A. RISK FACTORS In addition to the other information set forth in this report, you should carefully consider the factors discussed in Part I, Item 1A, \u201cRisk Factors\u201d of our 2025 10-K, which could materially affect our business, financial condition or future results. The risks described in our 2025 10-K are not the only risks facing us. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition or future results. There have been no material changes to the risk factors as disclosed in our 2025 10-K. ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS Issuer Purchases of Equity Securities (a) Second Quarter 2026 For the Month Ended Total Number of Shares Pu"
  }
}

RAG — SEC HIGHLIGHTS:
[From Pinecone cache] Based on the provided risk factors from the Annual Report on Form 10-K for UNH, the key takeaways regarding potential risks to the company’s business, financial position, and operations include:

**1. Medical Cost Management and Profitability Risks**
*   **Reliance on Estimates:** The profitability of risk-based products, which constitute nearly 80% of total consolidated revenues, depends heavily on the ability to accurately predict, price, and manage medical costs.
*   **Impact of Variability:** Small differences between predicted and actual medical costs or utilization rates can lead to significant changes in financial results.
*   **Unrecoverable Costs:** Factors such as medical cost inflation, increased service usage, provider billing intensity, pandemics, climate change effects, and new drug costs can cause actual expenses to exceed estimates. These excess costs generally cannot be recovered through higher premiums during the fixed contract period.
*   **Value-Based Care Challenges:** For Optum Health’s fully accountable value-based arrangements, failure to deliver higher-quality outcomes at lower costs or to successfully integrate care delivery models could adversely affect financial results.

**2. Cybersecurity and Data Privacy Threats**
*   **Significant Incidents:** The company has faced cyberattacks, including a notable incident in 2024 involving its Change Healthcare business, which compromised protected health information and personally identifiable information.
*   **Sophisticated Threats:** Risks are increasing due to sophisticated techniques, including the use of evolving AI technologies (such as generative AI) by threat actors to exploit vulnerabilities, deploy ransomware, or disrupt systems.
*   **Consequences:** Successful attacks or data breaches could result in revenue loss, increased costs, operational disruptions, regulatory penalties, litigation, and reputational harm.
*   **Third-Party Risks:** The company relies on third-party vendors for data processing, which introduces additional risks outside of direct oversight.

**3. Technology Systems and Data Integrity**
*   **System Integration and Upgrades:** Failure to successfully consolidate, integrate, upgrade, or expand information systems could result in higher-than-expected costs and operational failures.
*   **Data Accuracy:** The business relies on the integrity, timeliness, and accuracy of data. Inaccurate, incomplete, or outdated data can lead to pricing errors, fraud detection failures, customer disputes, and regulatory sanctions.
*   **AI and Innovation:** The company anticipates that fast-evolving AI technologies will play an increasingly important role. However, failing to keep pace with technological changes, regulatory standards, or customer preferences could lead to reputational harm and adverse business effects.
*   **Software Defects:** Software products sold or installed by the company may contain design defects or encounter complications, potentially affecting operational results.

**4. Regulatory and Legal Environment**
*   **Evolving Regulations:** Uncertain and rapidly evolving laws related to health data, health information technologies, and AI may alter the competitive landscape and impose new compliance requirements.
*   **Forward-Looking Statements:** The report contains forward-looking statements that are subject to risks and uncertainties. Actual results may differ materially from these projections, and the company does not undertake an obligation to update these statements to reflect new events.

RAG — RISK FACTORS:
[From Pinecone cache] The primary risk factors disclosed include:

*   **Inaccurate Cost Estimation and Management:** Failure to accurately predict, price, or manage medical costs under risk-based products and value-based arrangements could materially adversely affect financial results. This is due to the variability in benefit expense estimates and factors such as medical cost inflation, increased service utilization, provider billing intensity, pandemics, climate change effects, and the introduction of costly new drugs or technologies.
*   **Data Integrity and Information Systems:** Risks associated with the integrity, availability, and timeliness of data, as well as the successful consolidation, integration, and upgrade of information systems. Issues may arise from inaccurate data, failures in systems powered by artificial intelligence (AI), or the inability to keep pace with technological changes, potentially leading to regulatory sanctions, increased operating expenses, or reputational harm.
*   **Cybersecurity and Data Privacy:** Exposure to cyberattacks, privacy breaches, and data security incidents involving protected personal information or proprietary data. These incidents could result in operational disruptions, significant liability, reputational harm, and increased costs. The sophistication of threats, including those leveraging AI, and vulnerabilities in third-party vendors or recently acquired businesses (such as the Change Healthcare incident) are noted concerns.
*   **Regulatory and Legal Compliance:** Uncertain and rapidly evolving laws and regulations related to health data and health information technologies, including AI, which may alter the competitive landscape or impose new compliance requirements.
*   **Software and Technology Defects:** Risks that software products sold or installed may contain design defects or encounter complications during installation or use, potentially affecting results of operations if they fail to operate as intended.
*   **Provider and Payer Relationships:** Failure to maintain satisfactory relationships with healthcare payers, physicians, hospitals, and other service providers could materially and adversely affect the business.

## Pre-written sections (judge input)

### Financial Health

UnitedHealth Group (UNH) trades at $371.90 with a market capitalization of approximately $333.8 billion, reflecting its dominant position in the healthcare sector. The company reports trailing revenue of $450.5 billion and a net income of $14.1 billion, resulting in a profit margin of 3.14%. Its current P/E ratio stands at 23.92, while the forward P/E of 16.45 suggests anticipated earnings growth and a potentially more attractive valuation moving forward. Despite being down from its 52-week high of $461.62, the stock remains well above its 52-week low of $255.97, indicating resilience. Overall, the financial profile demonstrates strong revenue generation with improving forward-looking valuation metrics.

### Recent Developments

UnitedHealth Group filed its 2025 Annual Report (10-K) on March 2, 2026, reaffirming standard forward-looking statement protections without introducing new material risk factors. The company subsequently submitted its Second Quarter 2026 10-Q on August 10, 2026, which confirmed no significant changes to the risk profile outlined in the annual filing. While the 10-Q details routine equity repurchase activities, it does not disclose any major strategic shifts or operational disruptions. Investors should monitor upcoming earnings calls for updates on medical cost trends and regulatory impacts, as current filings indicate a stable but cautious operational environment.

### SEC Filing Highlights

UnitedHealth Group’s profitability remains highly sensitive to medical cost variability, as risk-based products comprise nearly 80% of revenue and rely on accurate cost predictions that are vulnerable to inflation and utilization spikes. The company faces significant cybersecurity and data privacy risks, highlighted by the 2024 Change Healthcare breach and escalating threats from sophisticated actors utilizing generative AI. Operational resilience is further challenged by the complexities of integrating technology systems and ensuring data integrity, where failures can lead to pricing errors and regulatory sanctions. Additionally, evolving regulations surrounding health data and AI introduce ongoing compliance uncertainties that may alter the competitive landscape and impose new operational requirements.

### Risk Factors

*   **Inaccurate Cost Estimation:** Failure to accurately predict or manage medical costs under risk-based products, driven by factors such as medical inflation, utilization spikes, and costly new technologies, could materially adversely affect financial results.
*   **Cybersecurity and Data Integrity:** Exposure to sophisticated cyberattacks, privacy breaches, and AI-related system failures poses significant risks of operational disruption, regulatory sanctions, and reputational harm, as highlighted by recent incidents like the Change Healthcare breach.
*   **Regulatory and Legal Compliance:** Rapidly evolving laws and regulations concerning health data, information technology, and AI may alter the competitive landscape and impose new, costly compliance requirements.

## Audited (Exec Summary + Outlook)

### Executive Summary
UnitedHealth Group (UNH) is a dominant healthcare conglomerate with a market capitalization of approximately $333.8 billion, generating trailing revenue of $450.5 billion and demonstrating resilience despite trading below its 52-week high of $461.62. The stock is currently notable for its improving forward-looking valuation, indicated by a forward P/E of 16.45, which contrasts with the current P/E of 23.92 and suggests anticipated earnings growth. The single most important near-term variable shaping the investment outcome is the company’s ability to accurately manage medical cost variability and navigate escalating cybersecurity threats.

### Outlook
The directional outlook for UnitedHealth Group is cautiously constructive, supported by a dominant market position and an improving forward valuation profile that suggests anticipated earnings growth. However, this thesis is heavily contingent on the company’s ability to stabilize medical cost trends and maintain robust cybersecurity defenses against escalating threats. Investors should closely monitor the trajectory of medical inflation and utilization rates, as well as the operational impact of integrating new technologies, as sustained pressure in these areas could weaken the investment case. Conversely, successful mitigation of these risks and continued execution of routine strategic initiatives would reinforce the current positive stance.

---
*This brief is for informational purposes only and does not constitute financial advice.*

## Judge findings

I will now systematically evaluate every specific quantitative figure, price target, threshold, ratio, metric, percentage, named product milestone, or forward-looking number in the **Executive Summary** and **Outlook** sections.

---

**EXECUTIVE SUMMARY**

---

CLAIM: "market capitalization of approximately $333.8 billion"
LABEL: SUPPORTED
REASON: The raw source data lists market_cap as 333,815,513,088.0, which rounds to approximately $333.8 billion, consistent with the pre-written Financial Health section.

---

CLAIM: "trailing revenue of $450.5 billion"
LABEL: SUPPORTED
REASON: The raw source data lists revenue as 450,525,986,816.0, which rounds to $450.5 billion, matching the pre-written Financial Health section.

---

CLAIM: "trading below its 52-week high of $461.62"
LABEL: SUPPORTED
REASON: The raw source data confirms week_52_high = $461.62 and current_price = $371.90; $371.90 < $461.62, so the stock is indeed trading below its 52-week high.

---

CLAIM: "forward P/E of 16.45"
LABEL: SUPPORTED
REASON: The raw source data lists forward_pe = 16.448336, which rounds to 16.45, matching the pre-written Financial Health section.

---

CLAIM: "current P/E of 23.92"
LABEL: SUPPORTED
REASON: The raw source data lists pe_ratio = 23.916397, which rounds to 23.92, matching the pre-written Financial Health section.

---

**OUTLOOK**

The Outlook section contains no additional specific quantitative figures, price targets, thresholds, ratios, metrics, percentages, named product milestones, or forward-looking numbers beyond directional and qualitative statements. All claims in the Outlook are qualitative or directional in nature (e.g., "cautiously constructive," "dominant market position," "improving forward valuation profile," "anticipated earnings growth," "medical inflation and utilization rates," "integrating new technologies") and do not introduce any new quantitative claims requiring verification.

No additional entries are required for the Outlook section.
